Investors delivered a sharp verdict on Unilever’s latest strategic shift, sending the consumer goods giant’s stock down approximately 7% following its decision to exit the food business entirely. The company plans to merge this division with U.S.-based spice manufacturer McCormick & Company in a deal valuing the combined entity at $44.8 billion.
A Pivot to Premium Segments
The move is a cornerstone of CEO Fernandez’s strategy to refocus Unilever into a pure-play company centered on beauty, wellness, and home care. These segments are perceived to offer superior profit margins and more consistent growth compared to the food unit, which has faced headwinds from shifting consumer preferences, the rise of weight-loss drugs (GLP-1), and intense competition from cheaper retailer private-label brands.
Under the transaction, iconic brands including Knorr and Hellmann’s will be combined with McCormick’s portfolio. Unilever shareholders are slated to retain a 65% stake in the newly formed food company, representing an equity value of roughly $29.1 billion. Furthermore, Unilever will receive a cash consideration of $15.7 billion, earmarked partly for debt reduction and a share buyback program worth €6 billion scheduled for the period between 2026 and 2029.
Market Skepticism Over Deal Complexity
Despite the multi-billion dollar valuation, the market reaction was decidedly negative, with the share price hitting a new 52-week low of €48.36 on Wednesday. Analysts have expressed significant concerns regarding the transaction’s structure. Experts at RBC Capital Markets noted the arrangement hardly constitutes a “clean break.” Because shareholders will maintain a majority stake in the new food behemoth, a technical “overhang” is created; many institutional investors may seek to divest these shares or could be restricted from holding them due to fund mandates.
Should investors sell immediately? Or is it worth buying Unilever?
This complex ownership structure is expected to weigh on Unilever’s valuation until the deal’s anticipated completion in mid-2027.
Significant Costs and Regulatory Scrutiny Ahead
The path to separation is fraught with expense and regulatory hurdles. Unilever anticipates incurring “stranded costs”—expenses related to shared infrastructure that will remain with the core company post-divestment—of up to €500 million. Total restructuring costs for the entire process are estimated at €1.2 billion.
Additionally, the merger is likely to face rigorous examination from U.S. regulators, specifically the Federal Trade Commission (FTC). Consolidation within the food industry is currently under heightened scrutiny over potential consumer price increases, which could prolong the approval process.
The central question for investors now is whether the promised benefits of a more focused business—namely improved efficiency and higher growth—will ultimately offset the substantial costs of the split and the loss of scale from a smaller corporate entity.
Ad
Unilever Stock: Buy or Sell?! New Unilever Analysis from April 2 delivers the answer:
The latest Unilever figures speak for themselves: Urgent action needed for Unilever investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 2.
Unilever: Buy or sell? Read more here...












